SPECIAL EMPHASIS PANELS
To view other meetings from ZHL1 choose calendar year:
| Study Section | Panel Name | Meeting Rosters |
|---|---|---|
| ZHL1 CCT-C(C1) | NHLBI CONTRACT REVIEW | 12/13/23 |
| ZHL1 CSR-O(J2) | CATALYZE PRODUCT DEFINITION | 12/11/23 |
| ZHL1 CSR-O(J1) | CATALYZE ENABLING TECHNOLOGIES | 12/04/23 |
| ZHL1 CSR-K(J2) | T32 MEMBER CONFLICTS SEP | 12/01/23 |
| ZHL1 CSR-G(J1) | MENTORED PATIENT ORIENTED REVIEW | 11/17/23 |
| ZHL1 CSR-L(J2) | NHLBI SUPPORT FOR CONFERENCE AND SCIENTIFIC MEETINGS (R13) | 11/16/23 |
| ZHL1 CSR-F(J1) | CATALYZE PRODUCT DEFINITION (R61/R33) | 11/16/23 |
| ZHL1 CSR-A(J1) | EDUCATION PROGRAM TO ENHANCE DIVERSITY IN BIOMEDICAL RESEARCH | 11/13/23 |
| ZHL1 CSR-Z(J2) | GRANT REVIEW FOR NHLBI K AWARD RECIPIENTS (R03) | 11/09/23 |
| ZHL1 CSR-F(J3) | NHLBI MENTORED CAREER DEVELOPMENT K-AWARDS | 11/06/23 |
| ZHL1 CSR-L(J1) | NHLBI MOSAIC K99R00 REVIEW PANEL | 11/03/23 |
| ZHL1 CSR-K(J1) | NHLBI BIOREPOSITORY: SCIENTIFIC OPPORTUNITIES FOR EXPLORATORY RESEARCH (R21) | 10/27/23 |
| ZHL1 CSR-Z(J1) | CLINICAL TRIALS SEP (UG3, U24, R61) | 10/26/23 |
| ZHL1 CSR-F(J2) | EARLY PHASE CLINICAL TRIALS (R61/R33) | 10/18/23 |
| ZHL1 PPG-C(J1) | STUDIES OF VON WILLEBRAND DISEASE | 10/03/23 |
| ZHL1 PPG-C(O2) | FACTORS DETERMINING BLOOD GROUP IMMUNITY | 09/14/23 |
| ZHL1 CSR-Z(O4) | OPPORTUNITIES FOR COLLABORATIVE RESEARCH AT THE NIH CLINICAL CENTER (U01) | 09/08/23 |
| ZHL1 CSR-Q(O2) | PEDIATRIC HEART NETWORK CLINICAL RESEARCH CENTERS (UM1) | 08/17/23 |
| ZHL1 CSR-Q(O3) | PEDIATRIC HEART NETWORK DATA COORDINATING CENTER (U24) | 08/16/23 |
| ZHL1 CCT-I(C1) | NHLBI BIOREPOSITORY CONTRACT REVIEW | 08/16/23 |
| ZHL1 CSR-O(O2) | CATALYZE PRODUCT DEFINITION | 08/07/23 |
| ZHL1 CSR-O(O1) | CATALYZE ENABLING TECHNOLOGIES | 08/04/23 |
| ZHL1 CSR-L(O2) | NHLBI EMERGING INVESTIGATOR AWARD (R35 EIA) REVIEW MEETING | 08/03/23 |
| ZHL1 CSR-G(O1) | NHLBI MENTORED CAREER DEVELOPMENT K-AWARDS | 08/03/23 |
| ZHL1 CSR-O(O3) | MENTORED CAREER DEVELOPMENT AWARDS | 08/02/23 |
| ZHL1 CSR-F(O1) | SBIR PHASE IIB SMALL MARKET AND BRIDGE AWARDS (R44) | 07/27/23 |
| ZHL1 CSR-Z(O1) | CLINICAL TRIALS SEP (UG3, U24) | 07/27/23 |
| ZHL1 CSR-I(O1) | R35 OIA REVIEW MEETING | 07/26/23 |
| ZHL1 CSR-G(O2) | PROGRAM FOR INCLUSION AND DIVERSITY AMONG INDIVIDUALS ENGAGED IN HEALTH RELATED RESEARCH (PRIDE) R25 AND U24 | 07/24/23 |
| ZHL1 CSR-G(O3) | NIH SUPPORT FOR CONFERENCES AND SCIENTIFIC MEETINGS (R13) | 07/18/23 |
| ZHL1 CSR-Q(O1) | PHYSICIAN SCIENTIST TRANSITION TO INDEPENDENCE IN BLOOD SCIENCE (R00) | 07/12/23 |
| ZHL1 CSR-Z(O2) | TRAINING PROGRAMS FOR INSTITUTIONS THAT PROMOTE DIVERSITY (T32) | 07/10/23 |
| ZHL1 CSR-K(O2) | GRANT REVIEW FOR NHLBI K AWARD RECIPIENTS | 06/29/23 |
| ZHL1 CSR-F(O2) | CATALYZE: PRODUCT DEFINITION | 06/27/23 |
| ZHL1 CSR-L(O1) | MOSAIC K99/R00 | 06/23/23 |
| ZHL1 PPG-Z(O3) | PPG SPECIAL EMPHASIS PANEL | 06/16/23 |
| ZHL1 CSR-A(A1) | HEAL: SLEEP PREDICTORS OF OPIOID USE DISORDERS TREATMENT REVIEW | 06/15/23 |
| ZHL1 CSR-I(O2) | R38 STARR REVIEW MEETING | 06/15/23 |
| ZHL1 CSR-B(O1) | T35 TRAINING GRANTS REVIEW | 06/08/23 |
| ZHL1 CSR-X(O1) | NRSA MEMBER CONFLICT PANEL | 06/06/23 |
| ZHL1 CSR-K(O1) | R25 RESEARCH EDUCATION PROGRAM TO ENHANCE DIVERSITY | 05/25/23 |
| ZHL1 PPG-C(M1) | RED CELL ALLOIMMUNIZATION | 04/17/23 |
| ZHL1 CSR-O(M1) | CATALYZE ENABLING TECHNOLOGIES | 04/07/23 |
| ZHL1 CSR-B(M2) | R13 CONFERENCE GRANT REVIEW | 04/06/23 |
| ZHL1 CSR-O(M2) | CATALYZE PRODUCT DEFINITION | 04/05/23 |
| ZHL1 CSR-Z(M1) | CLINICAL TRIALS SEP (UG3, U24, R61) | 03/30/23 |
| ZHL1 CSR-G(M1) | NHLBI MENTORED CAREER DEVELOPMENT K-AWARDS | 03/16/23 |
| ZHL1 CSR-Q(M1) | NHLBI TOPMED: OMICS PHENOTYPES OF HEART, LUNG, AND BLOOD DISORDERS (X01) | 03/16/23 |
| ZHL1 CSR-F(M2) | CATALYZE: PRODUCT DEFINITION | 03/14/23 |
| ZHL1 CSR-K(M1) | NHLBI BIOREPOSITORY: SCIENTIFIC OPPORTUNITIES FOR EXPLORATORY RESEARCH (R21) | 03/10/23 |
| ZHL1 PPG-Z(M2) | PPG REVIEW SEP | 03/10/23 |
| ZHL1 CSR-A(M1) | MENTORED CAREER DEVELOPMENT TO PROMOTE FACULTY DIVERSITY IN RESEARCH | 03/09/23 |
| ZHL1 CSR-L(M1) | REGENERATIVE MEDICINE INNOVATION PROJECT INVESTIGATOR-INITIATED CLINICAL TRIALS GRANT REVIEW | 03/07/23 |
| ZHL1 CSR-I(M1) | K38 REVIEW MEETING | 03/03/23 |
| ZHL1 CSR-L(M2) | REGENERATIVE MEDICINE INNOVATION PROJECT REVIEW | 03/02/23 |
| ZHL1 CCT-G(C1) | PHASE II SBIR TOPIC 110 PROPOSALS | 02/22/23 |
| ZHL1 CSR-G(M2) | NEW EPIDEMIOLOGICAL COHORT STUDY AMONG ASIAN AMERICANS, NATIVE HAWAIIANS, AND PACIFIC ISLANDERS: CLINICAL/COMMUNITY FIELD CENTERS (UG3-UH3) | 02/14/23 |
| ZHL1 CSR-G(M3) | NEW EPIDEMIOLOGICAL COHORT STUDY AMONG ASIAN AMERICANS, NATIVE HAWAIIANS, AND PACIFIC ISLANDERS: COORDINATING CENTER (U24) | 02/14/23 |
| ZHL1 CSR-F(M1) | EARLY PHASE CLINICAL TRIALS (R61/R33) | 02/09/23 |
| ZHL1 CCT-I(C1) | NHLBI CONTRACT REVIEW | 02/02/23 |
| ZHL1 CCT-Z(C1) | SBIR CONTRACT REVIEW | 01/24/23 |